Steve Cho
- Genetics top 5%
- Glioma Diagnosis and Treatment 22
-
- Medical Imaging Techniques and Applications 12
- Radiopharmaceutical Chemistry and Applications 7
- Radiomics and Machine Learning in Medical Imaging 6
- Transplantation top 5%
-
- Prostate Cancer Treatment and Research 6
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 14
-
- Meningioma and schwannoma management 13
-
- Pituitary Gland Disorders and Treatments 8
Steve Cho
69 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Genetics 292
- Radiology, Nuclear Medicine and Imaging 481
- Transplantation 51
- Pulmonary and Respiratory Medicine 408
- Biomedical Engineering 474
Countries citing papers authored by Steve Cho
This map shows the geographic impact of Steve Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Cho more than expected).
Fields of papers citing papers by Steve Cho
This network shows the impact of papers produced by Steve Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Cho. The network helps show where Steve Cho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steve Cho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 77 | |
| 6 | The roles of SOCS3 in myeloid cell-derived neovascular endothelium formation in a laser-induced choroidal neovascularization mouse model | 2021 | 1 |
| 7 | 2021 | 2 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 4 | |
| 10 | 2019 | 25 | |
| 11 | 2019 | 89 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 28 | |
| 14 | 2019 | 10 | |
| 15 | 2018 | 168 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 43 | |
| 19 | 2017 | 82 | |
| 20 | 2010 | 16 |
About Steve Cho
Steve Cho is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (22 papers), Nanoplatforms for cancer theranostics (14 papers), Meningioma and schwannoma management (13 papers), Medical Imaging Techniques and Applications (12 papers), Pituitary Gland Disorders and Treatments (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Prostate Cancer Treatment and Research (6 papers). The work is most often cited by research in Genetics (292 citations), Radiology, Nuclear Medicine and Imaging (481 citations) and Transplantation (51 citations). Steve Cho has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include John Y. K. Lee, Ryan Salinas, Sunil Singhal, J. Thomas Pierce, Ryan Zeh, Clare W. Teng, Alan B. McMillan, Richard L. Wahl, Habib Zaidi and Arman Rahmim. Their work appears in journals such as World Neurosurgery, Molecular Imaging and Biology, Operative Neurosurgery, Neurosurgery and Journal of Korean Neurosurgical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.